EUVIMEDEUVIMED entdecken
Crossref

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Cassandra Grello iD, Monica Demecillo, Kristyn Pierce, Sylwia Jasinski, Elizabeth Raetz iD, Francis Andrew De Los Reyes

Pediatric Blood & Cancer · 2026

DOI: 10.1002/pbc.70000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Cassandra Grello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, New York Presbyterian-Weill Cornell, New York City, New York, USA. Hauptthemen laut MEDLINE: Methotrexate, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neurotoxicity Syndromes, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate (MTX) has improved survival for children with acute lymphoblastic leukemia, but is associated with a 3%–7% incidence of neurotoxicity. This retrospective study showed a higher incidence of MTX neurotoxicity (11.3%) with the classic presentations of stroke‐like syndrome (17/19), seizures (2/19), and the majority (14/19) showing characteristic radiographic findings. Most cases occurred during the consolidation phase, a median of 6 days after MTX exposure. Older age, Hispanic ethnicity, greater body mass index, and National Cancer Institute high‐risk status were predictors of neurotoxicity, with only ethnicity remaining significant in adjusted analyses. Prophylactic leucovorin after repeated intrathecal MTX doses may be protective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaNeurotoxicity SyndromesAntimetabolites, AntineoplasticHumansRetrospective StudiesChildFemaleMaleChild, PreschoolAdolescentRisk FactorsYoung AdultInfantAdultPrognosis

Stichwörter der Autor:innen

ALLmethotrexateneurotoxicitystroke‐like syndrome

Substanzen

MethotrexateAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Pediatrics, New York Presbyterian-Weill Cornell, New York City, New York, USA.
  • Department of Pediatrics, NYU Langone Health, New York City, New York, USA.

ORCID-Profile: Cassandra Grello, Elizabeth Raetz

Zitieren

APA

Grello, C., Demecillo, M., Pierce, K., Jasinski, S., Raetz, E., & Reyes, F. A. L. (2026). A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.70000

Vancouver

Grello C, Demecillo M, Pierce K, Jasinski S, Raetz E, Reyes FAL. A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.70000

BibTeX
@article{Grello2026,
  author = {Grello, Cassandra and Demecillo, Monica and Pierce, Kristyn and Jasinski, Sylwia and Raetz, Elizabeth and Reyes, Francis Andrew De Los},
  title = {A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/pbc.70000}
}
Kostenlos starten →